| Lastest Insider Transactions Of UroGen Pharma Ltd. ( URGN ) | |||||||||
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2024-03-18 | Sell | 12,000 | 14.05 | 168,600 | 2024-03-20 16:38:32 |
| URGN | UroGen Pharma Ltd. | Kim Dong | Chief Financial Officer | 2024-01-31 | Option Exercise | 3,333 | 0.00 | 0 | 2024-02-12 17:47:51 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2024-01-31 | Sell | 4,993 | 15.78 | 78,790 | 2024-02-05 21:16:49 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2024-01-31 | Sell | 3,789 | 15.78 | 59,790 | 2024-02-05 21:15:14 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2024-01-31 | Sell | 4,993 | 15.74 | 78,590 | 2024-02-02 19:12:24 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2024-01-31 | Option Exercise | 10,000 | 0.00 | 0 | 2024-02-02 19:12:24 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2024-01-31 | Sell | 3,789 | 15.74 | 59,639 | 2024-02-02 19:07:36 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2024-01-31 | Option Exercise | 6,666 | 0.00 | 0 | 2024-02-02 19:07:36 |
| URGN | UroGen Pharma Ltd. | Kim Dong | Chief Financial Officer | 2024-01-31 | Option Exercise | 3,333 | 0.00 | 0 | 2024-02-02 19:05:51 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2023-08-31 | Sell | 3,800 | 18.01 | 68,438 | 2023-09-05 16:28:18 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2023-08-31 | Option Exercise | 8,334 | 0.00 | 0 | 2023-09-05 16:28:18 |
| URGN | UroGen Pharma Ltd. | Nussbaum Ran | Directior | 2022-06-06 | Option Exercise | 1,030 | 5.00 | 5,150 | 2023-02-28 12:29:13 |
| URGN | UroGen Pharma Ltd. | Nussbaum Ran | Directior | 2022-10-21 | Option Exercise | 47,999 | 5.94 | 285,114 | 2023-02-28 12:23:21 |
| URGN | UroGen Pharma Ltd. | Nussbaum Ran | Directior | 2022-06-16 | Option Exercise | 2,211 | 5.00 | 11,055 | 2023-02-28 12:21:59 |
| URGN | UroGen Pharma Ltd. | Barrett Elizabeth A. | Chief Executive Officer | 2023-01-31 | Option Exercise | 18,333 | 0.00 | 0 | 2023-02-02 15:40:58 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2023-01-31 | Sell | 1,636 | 10.12 | 16,556 | 2023-02-02 13:04:04 |
| URGN | UroGen Pharma Ltd. | Smith Jason Drew | General Counsel | 2023-01-31 | Option Exercise | 3,333 | 0.00 | 0 | 2023-02-02 13:04:04 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2023-01-31 | Sell | 1,900 | 10.12 | 19,228 | 2023-02-02 13:02:20 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2023-01-31 | Option Exercise | 3,833 | 0.00 | 0 | 2023-02-02 13:02:20 |
| URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Officer | 2023-01-20 | Option Exercise | 122,677 | 5.00 | 613,385 | 2023-01-23 19:10:39 |
